Frank Pitzer has been named CEO of Roche NimbleGen, Roche said last week. He replaces Gerd Maass, who led Roche NimbleGen for two years.
Pitzer most recently served as head of divisional quality and regulatory affairs at Roche Diagnostics. He holds a PhD in biology from the Max Planck Institute for Biochemistry.
Michelle Lyles has been named vice president of sales at Hamilton Thorne, the company said last week.